These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4425844

  • 1. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS, Chantler C, Ogg CS, White RH.
    Br Med J; 1974 Oct 05; 4(5935):7-11. PubMed ID: 4425844
    [Abstract] [Full Text] [Related]

  • 2. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
    Pediatr Nephrol; 2003 Apr 05; 18(4):351-6. PubMed ID: 12700961
    [Abstract] [Full Text] [Related]

  • 3. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis.
    Sheth KJ, Liu CC, Good TA.
    Wis Med J; 1974 May 05; 73(5):S55-60. PubMed ID: 4830366
    [No Abstract] [Full Text] [Related]

  • 4. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA, Lien JW, Aber GM.
    Clin Nephrol; 1979 Jan 05; 11(1):26-30. PubMed ID: 428152
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW, Shibuya M, Lu WH, Lewy JE.
    J Pediatr; 1973 Apr 05; 82(4):614-8. PubMed ID: 4698338
    [No Abstract] [Full Text] [Related]

  • 6. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.
    Am J Kidney Dis; 2017 May 05; 69(5):637-646. PubMed ID: 28089478
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J, Drummond KN.
    J Pediatr; 1974 Jun 05; 84(6):825-30. PubMed ID: 4855503
    [No Abstract] [Full Text] [Related]

  • 8. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Jun 05; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM, Bercowsky A, Osofsky SG, Soothill JF.
    Lancet; 1975 Jan 11; 1(7898):55-8. PubMed ID: 46019
    [Abstract] [Full Text] [Related]

  • 10. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 11. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug 24; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract] [Full Text] [Related]

  • 12. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ, Grushkin CM, Lieberman E.
    Pediatrics; 1976 Jun 24; 57(6):948-51. PubMed ID: 934751
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA, Levtchenko EN, Wetzels JF.
    Am J Kidney Dis; 2007 May 24; 49(5):592-7. PubMed ID: 17472840
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR, Feest TG, Morley AR, Tomlinson BE, Kerr DN.
    Lancet; 1972 Jun 10; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract] [Full Text] [Related]

  • 15. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J, Murphy AV, Arneil GC.
    Lancet; 1974 Oct 26; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
    Moncrieff MW, White RH, Oggs CS, Cameron JS.
    Br Med J; 1969 Mar 15; 1(5645):666-71. PubMed ID: 5774315
    [Abstract] [Full Text] [Related]

  • 17. A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.
    Adeniyi A, Hendrickse RG, Soothill JF.
    Arch Dis Child; 1979 Mar 15; 54(3):204-7. PubMed ID: 373645
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR.
    Int J Pediatr Nephrol; 1985 Mar 15; 6(4):245-50. PubMed ID: 4093243
    [Abstract] [Full Text] [Related]

  • 19. Differential protein clearances and response to treatment in Nigerian nephrotic children.
    Adeniyi A, Hendrickse RG, Soothill JF.
    Arch Dis Child; 1976 Sep 15; 51(9):691-6. PubMed ID: 793539
    [Abstract] [Full Text] [Related]

  • 20. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 15; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.